BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15547744)

  • 1. Cdx2 expression in pancreatic tumors: Relationship with prognosis of invasive ductal carcinomas.
    Matsumoto K; Mizoshita T; Tsukamoto T; Ogasawara N; Hirata A; Shimizu Y; Haneda M; Yamao K; Tatematsu M
    Oncol Rep; 2004 Dec; 12(6):1239-43. PubMed ID: 15547744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
    Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
    Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
    APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells.
    Mizoshita T; Inada K; Tsukamoto T; Nozaki K; Joh T; Itoh M; Yamamura Y; Ushijima T; Nakamura S; Tatematsu M
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):29-36. PubMed ID: 14615935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
    Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
    Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
    Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
    Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
    Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
    Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric- and intestinal-type marker expression in invasive ductal adenocarcinoma of the pancreas.
    Takano Y; Ohike N; Tajiri T; Asonuma K; Harada K; Takahashi H; Morohoshi T
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):424-8. PubMed ID: 22893471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
    Kermanshahi TR; Jayachandran P; Chang DT; Pai R
    Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas.
    Zen Y; Fujii T; Itatsu K; Nakamura K; Minato H; Kasashima S; Kurumaya H; Katayanagi K; Kawashima A; Masuda S; Niwa H; Mitsui T; Asada Y; Miura S; Ohta T; Nakanuma Y
    Hepatology; 2006 Nov; 44(5):1333-43. PubMed ID: 17058219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z; Li J; Dong B; Huang X
    Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
    Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
    Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.
    Qin R; Wang NN; Chu J; Wang X
    World J Gastroenterol; 2012 Jul; 18(25):3296-302. PubMed ID: 22783055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
    Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
    Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.
    La Rosa S; Rigoli E; Uccella S; Chiaravalli AM; Capella C
    Virchows Arch; 2004 Sep; 445(3):248-54. PubMed ID: 15517368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma.
    Chang YT; Hsu C; Jeng YM; Chang MC; Wei SC; Wong JM
    J Gastroenterol Hepatol; 2007 Mar; 22(3):389-94. PubMed ID: 17295772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.